AKBA
Akebia Therapeutics, Inc.
$1.40
-0.03 (-2.10%)
At close · Jul 10
Market Cap
$375.56M
Shares
268,258,243
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-06-30 | — | |
| Investor Event Transcript | 2026-06-30 | — | |
| 8-K | 2026-06-22 | 2026-06-17 | |
| 8-K | 2026-05-07 | — | |
| 10-Q | 2026-05-07 | 2026-03-31 | |
| DEF 14A | 2026-04-28 | — | |
| 8-K | 2026-04-01 | 2026-03-27 | |
| 10-K | 2026-02-26 | 2025-12-31 | |
| 8-K | 2026-02-26 | — | |
| 8-K | 2026-01-30 | 2026-01-27 | |
| 8-K | 2026-01-12 | — | |
| 8-K | 2025-12-01 | 2025-11-28 | |
| 8-K | 2025-11-17 | 2025-11-12 | |
| 10-Q | 2025-11-10 | 2025-09-30 | |
| 8-K | 2025-11-10 | — | |
| 8-K | 2025-10-28 | — | |
| 10-Q | 2025-08-07 | 2025-06-30 | |
| 8-K | 2025-08-07 | — | |
| 8-K | 2025-06-13 | 2025-06-10 | |
| 10-Q | 2025-05-08 | 2025-03-31 | |
| 8-K | 2025-05-08 | — | |
| DEF 14A | 2025-04-29 | — | |
| 8-K | 2025-03-20 | 2025-03-19 | |
| 10-K | 2025-03-13 | 2024-12-31 | |
| 8-K | 2025-03-13 | — | |
| 8-K | 2025-02-07 | 2025-02-03 | |
| 8-K | 2025-01-13 | — | |
| 10-Q | 2024-11-07 | 2024-09-30 | |
| 8-K | 2024-11-07 | — | |
| 8-K | 2024-10-22 | — | |
| 8-K | 2024-10-16 | 2024-10-15 | |
| 8-K | 2024-08-08 | — | |
| 10-Q | 2024-08-08 | 2024-06-30 | |
| 8-K | 2024-07-11 | 2024-07-10 | |
| 8-K | 2024-06-24 | 2024-06-21 | |
| 8-K | 2024-06-10 | 2024-06-06 | |
| 10-Q | 2024-05-09 | 2024-03-31 | |
| 8-K | 2024-05-09 | — | |
| DEF 14A | 2024-04-25 | — | |
| 8-K | 2024-04-23 | 2024-04-17 | |
| 8-K | 2024-04-16 | 2024-04-15 | |
| 8-K | 2024-03-28 | 2024-03-27 | |
| 8-K | 2024-03-15 | — | |
| 10-K | 2024-03-14 | 2023-12-31 | |
| 8-K | 2024-03-14 | — | |
| 8-K | 2024-02-13 | 2024-02-08 | |
| 8-K | 2024-01-30 | 2024-01-29 | |
| 8-K | 2024-01-08 | — | |
| 8-K | 2024-01-08 | — | |
| 8-K | 2023-12-18 | 2023-12-14 |
Showing 1–50 of 151 filings